MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-13-0005799
Kryptomed Formulations Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹6.59 Cr
▲ 3% YoY
Net profit · FY 2025
₹12.56 Lakh
Net margin 1.9%
EBITDA · FY 2025
₹23.5 Lakh
EBITDA margin 3.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
3
As per MCA filings
Active GSTINs
1
of 2 registered
About Kryptomed Formulations Private Limited
Data last updated:
Kryptomed Formulations Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 July 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24230CH2016PTC041139. Its GSTIN is 06AAGCK2346A1Z1 (Haryana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Kirti Mehta and Anshul Madan.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at SCO 827 Second Floor Nac Manimajra Chandigarh, Chandigarh, India – 160101.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.59 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹12.56 Lakh (net margin 1.9%) and EBITDA of ₹23.5 Lakh (EBITDA margin 3.6%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 17% over five years.
Court records list 3 cases involving the company, including 3 filed by the company; 3 cases are pending.
Kryptomed Formulations Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0005799). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kryptomed.com.
Company details
CIN U24230CH2016PTC041139
Registration Number 041139
Incorporation Date 20 July 2016
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HR-13-0005799
Recognitions & Rankings of Kryptomed Formulations
Contact details
Kryptomed Formulations Private Limited's registered office is in Chandigarh, Chandigarh. Its website is kryptomed.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressSCO 827 Second Floor Nac Manimajra Chandigarh, Chandigarh, India – 160101
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Kryptomed Formulations Private Limited, buy the company report.
Comprehensive company report
Kryptomed Formulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Kryptomed Formulations is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Kryptomed Formulations Private Limited, buy the company report.
Financials of Kryptomed Formulations Private Limited
FY 2024 filings availableKryptomed Formulations Private Limited reported revenue of ₹6.59 Cr (up 3% YoY) for FY 2025.
Revenue · FY 2025
₹6.59 Cr ▲ 3%
Net profit · FY 2025
₹12.56 Lakh margin 1.9%
EBITDA · FY 2025
₹23.5 Lakh margin 3.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 11%
5 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 20%
5 years · compounded
▲ 24%
Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 3% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹23.5 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.56 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.6% | ||||
| Net Profit Margin | 1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kryptomed Formulations Private Limited, buy the company report.
Board of directors of Kryptomed Formulations Private Limited
Kryptomed Formulations has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kirti Mehta | Director | 20 Jul 2016 | 10 Years 3 Months | Current |
| Anshul Madan Also directs: LKM Remedies Private Limited, Shagun Medi Testing Private Limited | Director | 20 Jul 2016 | 10 Years 3 Months | Current |
| Vipin Kumar | Director | 20 Jul 2016 | 10 Years 3 Months | Current |
Peer comparison
Kryptomed Formulations Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Fedley Healthcare Private Limited | ₹6.61 Cr (FY 2024) | -6.0% | Raipur Rani, Haryana, India | |||
| Winy Healthcare Private Limited | ₹6.6 Cr (FY 2024) | 17.0% | Agra, Uttar Pradesh, India | |||
| Kryptomed Formulations Private Limitedthis company | ₹6.59 Cr (FY 2025) | ₹12.56 Lakh | 1.9% | 3.0% | Chandigarh, India | |
| Menamed Pharma Private Limited | ₹6.58 Cr (FY 2025) | 26.0% | Delhi, India |
To see the full peer comparison of Kryptomed Formulations Private Limited, buy the company report.
Auditor
Kryptomed Formulations Private Limited is audited by AMIT BAJAJ & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AMIT BAJAJ & ASSOCIATES | FY 2024 | 519362 |
Shareholding
The shareholding of Kryptomed Formulations Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Kryptomed Formulations Private Limited, buy the company report.
Legal cases
Kryptomed Formulations Private Limited has 3 court cases on record: 3 filed by Kryptomed Formulations. All cases are pending.
Total cases
3
Filed by the company
3
Pending
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 3 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, Panchkula, Haryana | Court case (CS37) | Filed by the company against M/S Rama Agency Through Its Proprietor and 1 other | Pending |
| District court, Panchkula, Haryana | Court case (CS37) | Filed by the company against M/S Candor and 1 other | Pending |
To see the full case history of Kryptomed Formulations Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Kryptomed Formulations Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 28 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (3 of 3)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Ultra Drugs Private Limited | |||
| Merx Healthcare Communications Private Limited |
To see the full MSME payment records of Kryptomed Formulations Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Kryptomed Formulations has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAGCK2346A1Z1 | Haryana | Active | 29 Mar 2019 |
To see the full GST registrations and return filing status of Kryptomed Formulations Private Limited, buy the company report.
Recent activity
Kryptomed Formulations Private Limited has 3 board changes on record since 2016: 3 appointments. The latest: Anshul Madan was appointed as Director on 20 Jul 2016.
AGM
Kryptomed Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Kryptomed Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh.
Appointed
Anshul Madan was appointed as Director.
Appointed
Kirti Mehta was appointed as Director.
Appointed
Vipin Kumar was appointed as Director.
Incorporation
20 Jul 2016
Kryptomed Formulations Private Limited was registered on 20 Jul 2016 with Roc Chandigarh & aged 10 years 3 months as per MCA records.
Frequently asked questions
Kryptomed Formulations is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 July 2016 (10+ years old) and is registered under CIN U24230CH2016PTC041139.
Kryptomed Formulations has 3 current directors:
- Kirti Mehta - Director
- Anshul Madan - Director
- Vipin Kumar - Director
The latest financial statements of Kryptomed Formulations on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Kryptomed Formulations is 06AAGCK2346A1Z1, registered in Haryana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Kryptomed Formulations is U24230CH2016PTC041139. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kryptomed Formulations has 3 court cases on record: 3 filed by the company. 3 are pending.
Kryptomed Formulations was incorporated on 20 July 2016, making it 10+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Kryptomed Formulations by revenue are Fedley Healthcare Private Limited, Winy Healthcare Private Limited, Menamed Pharma Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Anshul Madan was appointed as Director on 20 Jul 2016. Kirti Mehta was appointed as Director on 20 Jul 2016. Vipin Kumar was appointed as Director on 20 Jul 2016.
Yes, Kryptomed Formulations is registered as a small enterprise under Udyam registration (number: UDYAM-HR-13-0005799).
Kryptomed Formulations has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 28 overdue payments to 3 micro and small suppliers. The latest return was filed on 21 Jun 2019.
Kryptomed Formulations can be reached through the website kryptomed.com. Its registered office is in Chandigarh, India.